Cargando…
Effective tumour necrosis factor-blocking therapy reduces reactive oxygen metabolite level in rheumatoid arthritis
OBJECTIVE: To assess circulating levels of derived reactive oxygen metabolites (ROMs) in patients with active rheumatoid arthritis (RA), before and during antitumour necrosis factor (TNF)-α therapy. METHODS: Patients with active RA and failed previous treatment with disease-modifying antirheumatic d...
Autores principales: | Cacciapaglia, Fabio, Grazia Anelli, Maria, Rizzo, Daniela, Morelli, Emma, Mazzotta, Daniela, Scioscia, Crescenzio, Iannone, Florenzo, Lapadula, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536522/ https://www.ncbi.nlm.nih.gov/pubmed/27683135 http://dx.doi.org/10.1177/0300060515593227 |
Ejemplares similares
-
Lipids and Atherogenic Indices Fluctuation in Rheumatoid Arthritis Patients on Long-Term Tocilizumab Treatment
por: Cacciapaglia, Fabio, et al.
Publicado: (2018) -
Synovial fluid from patients with rheumatoid arthritis modulates monocyte cell-surface phenotype
por: Chimenti, Maria Sole, et al.
Publicado: (2016) -
Intestinal epithelial suppressor of cytokine signaling 3 enhances microbial-induced inflammatory tumor necrosis factor-α, contributing to epithelial barrier dysfunction
por: Thagia, Imtiyaz, et al.
Publicado: (2014) -
S100A8/A9 in psoriatic plaques from patients with psoriatic arthritis
por: Chimenti, Maria Sole, et al.
Publicado: (2016) -
Salivary interleukin-1β: Oral inflammatory biomarker in patients with psoriasis
por: Ganzetti, Giulia, et al.
Publicado: (2016)